Expert opinions

(11) Notion of subsidiaries and capital groups in the light of the Competition and Consumers Protection Act, also taking into account Article 99(3) of the Pharmaceutical Law of 6 September 2001 (2015).

  • Activity: Scientific expertise
  • Title: Notion of ‘subsidiaries’ and ‘capital groups’ in the light of the Competition and Consumers Protection Act, also taking into account Article 99(3) of Pharmaceutical Law of 6 September 2001
  • Authors: Prof. dr. Taduesz Skoczny (University of Warsaw, Department of European Economic Law at the Faculty of Management)
  • Date of online publication: 4 February 2015

This expertise was commissioned by the Regional Apothecary Council in Warsaw. The purpose of this project was to clarify – on the basis of the Competition and Consumer Protection Act – the term ‘subsidiaries’ and ‘capital group’ as defined in Article 99(2)&(3) of Pharmaceutical Law. The latter are the basis for the issue of a permit to run a pharmacy issued by regional pharmaceutical inspectors.

Pojęcie podmiotów zależnych i grupy kapitałowej w świetle ustawy o ochronie konkurencji i konsumentów, z uwzględnieniem treści art. 99 ust. 3 ustawy z dnia 6 września 2001 r. Prawo farmaceutyczne Notion of ‘subsidiaries’ and ‘capital groups’ in the light of the Competition and Consumers Protection Act, also taking into account Article 99(3) of Pharmaceutical Law of 6 September 2001

CARS

Centre for Antitrust and Regulatory Studies,
University of Warsaw, Faculty of Management

PL - 02-678 Warsaw, 1/3 Szturmowa St.
website: www.cars.wz.uw.edu.pl (cars English site)

Contact Us